January 11, 2018 / 9:43 PM / Updated 11 minutes ago BRIEF-Dynasil Announces Submission Of Xcede Technologies' Application For First-In-Human Clinical Trial Reuters Staff 
Jan 11 (Reuters) - Dynasil Corporation Of America: 
* DYNASIL ANNOUNCES SUBMISSION OF XCEDE TECHNOLOGIES’ APPLICATION FOR FIRST-IN-HUMAN CLINICAL TRIAL 
* DYNASIL CORPORATION OF AMERICA - ‍ANTICIPATES THAT PATIENTS WILL BE TREATED WITH XCEDE PATCH IN NETHERLANDS IN EARLY 2018​ Source text for Eikon: Further company coverage: